CANNAINVESTOR Magazine U.S. Publicly Traded April 2018 | Page 41

OTC: NSHSF ; CSE: NSHS

PIONEERING NANO-BIOTECHNOLOGY COMPANY. WITH OVER 20 YEARS RESEARCHING AND DEVELOPING OUR PATENT-PENDING NANOSPHERE DELIVERY SYSTEMâ„¢.

PATENTED NANOSPHERE DELIVERY TECHNOLOGYâ„¢ INCREASES THE BIOAVAILABILITY AND BIOACTIVITY OF CANNABINOIDS.

NANOSPHERE HEALTH IS THE FIRST AND ONLY COMPANY TO NANO-SIZE AND ENCAPSULATE CANNABINOIDS, DRAMATICALLY CHANGING THE INDUSTRY.

41